vg-3927
vg-3927: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Vigil Neuroscience, Inc. (VIGL) | Phase 1 |
Get deeper analysis on vg-3927
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis